NCT03930797

Brief Summary

The objective of the proposed study is to evaluate an Intimacy Enhancement (IE) intervention in 120 female early stage breast cancer survivors reporting sexual concerns and their intimate partners (240 total participants). Couples will be randomized 1:1 to receive either the IE intervention or to an information and support condition (Living Healthy Together). The investigators will evaluate intervention effects on patient and partner sexual, relationship, and psychological outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started May 2019

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

May 24, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2023

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 11, 2024

Completed
Last Updated

July 11, 2024

Status Verified

June 1, 2024

Enrollment Period

3.9 years

First QC Date

April 24, 2019

Results QC Date

May 16, 2024

Last Update Submit

June 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Self-Reported Patient Sexual Function

    Patients' self-reported sexual function will be measured using the 19-item Female Sexual Function Index (FSFI).Total scale scores range from 2 to 36, with higher scores indicating higher functioning. Mean change scores will be reported: positive mean change scores indicate increase in sexual functioning over time while negative mean change scores indicate decrease in sexual functioning over time.

    Baseline up to 6 weeks

Secondary Outcomes (10)

  • Change in Self-Reported Partner Sexual Function

    Baseline up to 6 weeks

  • Change in Self-Reported Patient Sexual Distress

    Baseline up to 6 weeks

  • Change in Patients' Self-Reported Relationship Intimacy

    Baseline up to 6 weeks

  • Change in Partners' Self-Reported Relationship Intimacy

    Baseline up to 6 weeks

  • Change in Patients' Self-Reported Relationship Quality

    Baseline up to 6 weeks

  • +5 more secondary outcomes

Study Arms (2)

Intimacy Enhancement

EXPERIMENTAL

Participants attend four sessions (60-75 minutes) consisting of education and skills training to enhance physical and emotional intimacy.

Behavioral: Intimacy Enhancement

Living Healthy Together

ACTIVE COMPARATOR

Participants attend four sessions (60-75 minutes) consisting of information and support across a range of breast cancer-related topics.

Behavioral: Living Healthy Together

Interventions

The IE intervention is grounded in cognitive behavioral couple therapy and sex therapy, and includes education and skills training with a focus on the following major topics: understanding effects of breast cancer on sex and intimacy; goal-setting; communication skills; problem-solving and engaging in activities to build intimacy; identifying and restructuring negative or inflexible thoughts; and planning ahead and preparing for challenges. Participants will be asked to participate in written and behavioral activities at home between sessions to strengthen skills acquisition.

Intimacy Enhancement

The Living Healthy Together (LHT) intervention focuses on delivering education and support to breast cancer survivors and their partners across a range of topics including social support, sleep and fatigue, stress and stress management, nutrition, and physical activity. Participants will be asked to engage actively with the material and to review readings and intervention material between sessions.

Living Healthy Together

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is female
  • Patient age 18 years or older
  • Patient has a medically confirmed diagnosis of non-recurrent breast cancer (Stages T1-T4, N0-N1, M0)
  • Patient completed active treatment (e.g., chemotherapy, radiation therapy, surgery, immunotherapy) 6 months-5 years ago (current use of endocrine therapy is acceptable)
  • Patient is currently in a partnered relationship that could involve sexual activity
  • Partner or spouse is 18 years or older
  • Patient lives with a romantic partner for at least 6 months
  • Patient has a score of at least 3 on Patient Care Monitor Sexual Concerns screening item

You may not qualify if:

  • Patient or partner is not able to speak and read English, as stated in medical record, as observed by study team member or in self-report
  • Patient or partner ECOG Performance score \> 2 OR medically unable to participate as judged by physician/in medical record or by self-report
  • Patient or partner has a hearing impairment
  • Patient and partner do not have reliable telephone access
  • Patient has overt cognitive dysfunction or psychiatric disturbance such as suicidal ideation or severe mental illness, as observed or judged by the researcher, physician or referring source, or self-report
  • Patient past or current history of any cancer other than non-melanoma skin cancer, including prior breast cancer
  • Patient is currently participating in couple/marital therapy
  • Patient is currently pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fox Chase Cancer Center

Philadelphia, Pennsylvania, 19111, United States

Location

Related Publications (1)

  • Reese JB, Zimmaro LA, Lepore SJ, Sorice KA, Handorf E, Daly MB, Schover LR, Kashy D, Westbrook K, Porter LS. Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial. Trials. 2020 Feb 12;21(1):173. doi: 10.1186/s13063-019-3975-2.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Dr. Jennifer Reese, Associate Professor
Organization
Fox Chase Cancer Center

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2019

First Posted

April 29, 2019

Study Start

May 24, 2019

Primary Completion

April 14, 2023

Study Completion

April 14, 2023

Last Updated

July 11, 2024

Results First Posted

July 11, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations